NASDAQ:VIVE - Viveve Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.33
▼ -0.01 (-0.43%)

This chart shows the closing price for VIVE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Viveve Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VIVE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VIVE

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Viveve Medical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.33.

This chart shows the closing price for VIVE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Viveve Medical. This rating has held steady since June 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/29/2021Alliance Global PartnersInitiated CoverageBuyHigh
12/3/2019LADENBURG THALM/SH SHUpgradeNeutral ➝ BuyHigh
8/9/2019Maxim GroupReiterated RatingHoldMedium
7/24/2019LADENBURG THALM/SH SHDowngradeBuy ➝ NeutralHigh
7/23/2019Maxim GroupDowngradeBuy ➝ HoldN/A
7/23/2019MizuhoDowngradeBuy ➝ Underperform$4.00 ➝ $0.20N/A
7/23/2019Raymond JamesDowngradeOutperform ➝ Market PerformN/A
7/22/2019Stifel NicolausDowngradeBuy ➝ Hold$3.00 ➝ $1.00N/A
3/15/2019MizuhoReiterated RatingBuy$4.00High
2/11/2019Maxim GroupReiterated RatingBuy$6.00High
1/18/2019Craig HallumSet Price TargetHold$1.00High
1/17/2019Maxim GroupReiterated RatingBuyLow
12/12/2018Raymond JamesLower Price TargetOutperform ➝ Outperform$4.50 ➝ $3.00Low
5/11/2018Craig HallumDowngradeBuy ➝ HoldHigh
4/17/2018Stifel NicolausInitiated CoverageBuy ➝ Buy$6.00High
3/20/2018MizuhoReiterated RatingBuy$10.00Medium
3/16/2018Maxim GroupReiterated RatingBuy$11.00High
2/8/2018MizuhoReiterated RatingBuyHigh
2/1/2018MizuhoReiterated RatingBuy$10.00Medium
1/5/2018MizuhoReiterated RatingBuy$10.00Low
1/5/2018Northland SecuritiesInitiated CoverageOutperform ➝ Outperform$8.00Low
1/4/2018LADENBURG THALM/SH SHReiterated RatingBuyLow
11/16/2017MizuhoInitiated CoverageBuy ➝ Buy$10.00N/A
10/23/2017CowenSet Price TargetBuy$11.00N/A
8/17/2017CowenReiterated RatingBuy$11.00High
8/11/2017Maxim GroupReiterated RatingBuy$11.00High
5/25/2017Raymond JamesInitiated CoverageOutperform ➝ Outperform$10.00Medium
5/17/2017B. RileyReiterated RatingBuy$10.00Medium
5/12/2017B. RileyReiterated RatingBuy$10.00Low
5/3/2017CowenInitiated CoverageOutperform$11.00Low
2/22/2017B. RileyReiterated RatingBuy$10.00N/A
2/17/2017B. RileyReiterated RatingBuy$10.00N/A
11/18/2016B. RileyReiterated RatingBuy$8.00N/A
11/12/2016B. RileyReiterated RatingBuy$8.00N/A
11/7/2016B. RileyInitiated CoverageBuy$8.00N/A
11/2/2016B. RileyInitiated CoverageBuy$8.00N/A
9/20/2016LADENBURG THALM/SH SHInitiated CoverageBuy$22.00N/A
(Data available from 9/20/2016 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/22/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Viveve Medical logo
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company was founded on March 3, 1987 and is headquartered Englewood, CO.
Read More

Today's Range

Now: $2.33
Low: $2.31
High: $2.37

50 Day Range

MA: $2.52
Low: $2.33
High: $2.78

52 Week Range

Now: $2.33
Low: $2.30
High: $6.78

Volume

93,700 shs

Average Volume

890,412 shs

Market Capitalization

$24.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Viveve Medical?

The following Wall Street research analysts have issued stock ratings on Viveve Medical in the last year: Alliance Global Partners, and Zacks Investment Research.
View the latest analyst ratings for VIVE.

What is the current price target for Viveve Medical?

0 Wall Street analysts have set twelve-month price targets for Viveve Medical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Viveve Medical in the next year.
View the latest price targets for VIVE.

What is the current consensus analyst rating for Viveve Medical?

Viveve Medical currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VIVE will outperform the market and that investors should add to their positions of Viveve Medical.
View the latest ratings for VIVE.

What other companies compete with Viveve Medical?

How do I contact Viveve Medical's investor relations team?

Viveve Medical's physical mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company's listed phone number is (720) 696-8100 and its investor relations email address is [email protected] The official website for Viveve Medical is www.viveve.com.